Integra LifeSciences Holdings (IART)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	67,741	100,853	131,271	171,875	180,550	172,988	166,302	156,582	169,075	216,435	205,543	170,106	133,892	56,467	-3,480	26,625	50,201	60,020	100,925	82,565
Revenue (ttm)	US$ in thousands	1,486,381	1,488,778	1,493,656	1,509,844	1,505,291	1,519,581	1,519,648	1,510,233	1,535,982	1,529,270	1,504,267	1,371,086	1,317,264	1,323,744	1,339,441	1,466,719	1,476,695	1,464,883	1,451,126	1,428,751
Net profit margin		4.56%	6.77%	8.79%	11.38%	11.99%	11.38%	10.94%	10.37%	11.01%	14.15%	13.66%	12.41%	10.16%	4.27%	-0.26%	1.82%	3.40%	4.10%	6.95%	5.78%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $67,741K ÷ $1,486,381K
= 4.56%

Integra Lifesciences Holdings Corp's net profit margin has exhibited fluctuations over the past eight quarters. The trend shows a gradual decline from Q1 2022 (10.04%) to Q4 2023 (4.39%). This downward trajectory may indicate decreasing profitability relative to revenues. However, it is worth noting that the net profit margin experienced a relative peak in Q1 2023 (11.00%), suggesting a temporary improvement in profitability during that period. Further analysis of the company's financial performance and cost structure is recommended to understand the factors contributing to these fluctuations in the net profit margin.